Home » Topics » Regulatory

Regulatory
RSS

Schering-Plough seeks additional FDA approval for Rebetol capsules

Dec. 18, 2000

FDA approves pediatric indication for Tamiflu

Dec. 18, 2000

FDA clears new dose of Concerta for ADHD

Dec. 18, 2000

ODAC unanimously recommends approval of Femara as first-line breast cancer treatment

Dec. 15, 2000

New Claritin formulation receives FDA marketing approval

Dec. 14, 2000

FDA approves second indication for Antizol

Dec. 13, 2000

Galenic formulations of antithrombotic agents for s.c. administration

Dec. 12, 2000

FDA approves new indications for Prevacid

Dec. 12, 2000

Health Canada approves Asmanex Twisthaler for treatment of asthma

Dec. 12, 2000

Myobloc is first FDA-approved treatment for cervical dystonia

Dec. 11, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...